Are Louisiana Pharmacists PrEPared? Implementing Training and an Active PrEP (Pre-Exposure Prophylaxis) Prescribing Surveillance Program

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age24-99
SponsorXavier University of Louisiana.

About this trial

Though broadening PrEP (Pre-Exposure Prophylaxis) availability to Louisiana pharmacies addresses key access issues for Louisiana's population, there is no current baseline data which explore current pharmacist and pharmacies' capacity to effectively provide PrEP therapy to patients who meet PrEP prescribing criteria. This study aims to explore1) Louisiana pharmacist and pharmacy capacity to provide PrEP under a state-based collaborative practice agreement, 2) a validated pharmacist education system addressing health disparities in PrEP prescribing and 3) the impact of state pharmacy based policies on equitable PrEP prescribing. Our central hypothesis is pharmacist trained in PrEP prescribing focusing on health disparities and implicit bias education and working with mentors in an implementation framework will have an increase in equitable PrEP prescribing

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Community pharmacists in Louisiana providing PrEP prescriptions.

Disqualifiers

None

Trial population

All practicing community pharmacists who are interested in a PrEP education course on equitable PrEP prescribing to address health disparities among the target patient population.

Trial design

Design model

Ecologic or community

Time perspective

Prospective

Treatments tested in this trial

  • Education and Mentoring for Prescribing Pharmacists

    Other intervention

    Pharmacists enrolled in the PrEP prescribing cohort will receive implicit bias, health disparity and health equity training for HIV prevention. In addition, the pharmacists will receive mentorship and receive an implementation toolkit on best practices for PrEP prescribing.

Treatment groups

75 Participants
are divided into 1 treatment group
Group A: Community Based Pharmacies1 intervention

Trial outcomes

Primary outcomes

1

PrEP Prescribing

Number of PrEP prescriptions dispensed from pharmacy (Scale PrEP prescription/1,000 total prescriptions in 30 day period)

Time frame
May 1, 2025- April 30, 2029
2

Pharmacists' Knowledge and Confidence in PrEP prescribing

Pharmacists will complete a pre and post-test on knowledge and confidence in PrEP prescribing to target populations. Knowledge will be scored on a graded scale of 0 (lowest to 100 (highest). Confidence will be scored on a Likert Scale (1 - least confident, 5 most confident)

Time frame
May 1, 2025- April 30, 2026

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Xavier University of Louisiana.

Lead sponsor

Louisiana Public Health Institute

Collaborator

This trial is not recruiting at the moment. You can still explore other options: